Healing Through Innovation

Corporate Overview
March, 2017

V2.0 WEB
FORWARD LOOKING STATEMENT

This presentation contains forward-looking statements within the meaning of the private Securities
litigation Reform Act of 1995 and other securities laws. Forward-looking statements are not historical
facts, and are based upon managements current expectations, beliefs and projections, many of which,
by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in
good faith. However, there can be no assurance that managements expectations, beliefs and
projections will be achieved and actual results may differ materially from what is expressed in or
indicated by the forward-looking statements. Forward-looking statements are subject to risks and
uncertainties that could cause actual performance or results to differ materially from those expressed
in the forward-looking statements, including risks detailed in Mazor Robotics Ltd.s (Mazor Robotics
or the Company) annual reports on Form 20-F filed with the U.S. Securities and Exchange
Commission. The following solutions are pending FDA clearance: Intra-operative verification, Mazor X
Align, ArcAid device, Mazor X Lateral and Mazor X SIJ.

Forward-looking statements speak only as of the date the statements are made. The Company
assumes no obligation to update forward-looking statements to reflect actual results, subsequent
events or circumstances, changes in assumptions or changes in other factors affecting forward-looking
information except to the extent required by applicable securities laws. If the Company does update
one or more forward-looking statements, no inference should be drawn that the Company will make
additional updates with respect thereto or with respect to other forward-looking
m a zo rro bo tics . co m statements. 2
Investment Considerations

Pioneer and market leader of surgical robotics

revolution in Spine Surgery
Portfolio of spine guidance systems for the benefit of
patients and those who serve them

Proven core technology used in 23,000+

procedures to place 160,000+ implants
Strong balance sheet to support investment in
maintaining innovation leadership and expanding
commercialization

m a zo rro bo tics . co m 3
Customer Experience
Significant Commercial Installed Base

Intnl US

China
Japan
Global Organization and Installed Base
Taiwan

55% 208 145+

of company Total Commercial
employees are in Employees Installed Base
Legen the US
d
Mazor System 69 8 20
Australia US Clinical International US Capital
Mazor Offices
Sales Force Sales Team Sales Force
Training Center 3
sites m a zo rro bo tics . co m 4
 Technologyand
Technology andProduct
ProductExperience
Expertise

2001 Pioneers in Guided Systems

13 10 37
Granted FDA R&D Experts
Patents Clearances

40 15 3
Countries Years of Product
Cleared commercial Generations
For Clinical Use spine experience
m a zo rro bo tics . co m 5
Continuous Growth in Clinical Utilization

% MIS Procedures: Mazor vs. Spine Market

51% 51%
Type of cases(Revision / Deformities / Degenerative) 43% 45%

Mazor 15%
20%

Evidence Based Value

61%
19%

51% > 300 > 45

MIS cases Surgeons Published
Papers

23K + 160K + 99.0%

Cases Implants Placement
Accuracy
Revision Deformities Degenerative
m a zo rro bo tics . co m 6
Strength of Clinical Evidence Base
Clinical Evidence Benefits for Patients and Surgeons
Proven Reduction in Complications and
Consistent Accuracy with Improved Outcomes
Revisions (1)
Free-Hand Mazor

18.1%

5.2% 5.8%

0.9%

Proven Reduction in Exposure to Radiation (1)

62%

___________________________
1.Based on published data: Cannestra, e-poster NASS 2014; Kantelhardt, ESJ 2011; Ringel, ESJ 2012, Roser, 2013.
2.Freehand represents the average fluoro radiation exposure during a freehand operation as a baseline for comparison to Renaissance only.
m a zo rro bo tics . co m 7
 BusinessExperience
Business Experience

Business Model Value Proposition

46% > 72% 100%

Recurring Gross Margin Service Contracts
Sales (1)
US installs
$1,100k $1.5k $36m
Mazor X USA Disposables 2016
List Price List Price Revenues
1. Based on results 12 months ended 31 December 2016
m a zo rro bo tics . co m 8
Why Now? Robotic Revolution is Happening

The Spine surgical robotics market is expected to explode over the next five years
1. The surgical robot for spine market is currently $26 million and expected to explode to be worth $2.77
billion by 2022.
2. The report estimates when spinal robots achieve 35 percent penetration in a country, spinal surgeons will
demand hospitals offer the spinal surgical robot capabilities.
3. Reduced insurance payments impact the spine surgical market, as hospitals pay more attention to costs
and quality outcomes than in the past.
4. Mazor is the dominant company in the spine surgery robotics market, according to the report.
Mazor is the clear leader in the [spine guidance] field and
several years ahead of new entrants12/2016

*SurgicalRobots for the Spine: Market Shares, Strategy, and Forecasts,

Worldwide, 2016 to 2022, Winter Green Research m a zo rro bo tics . co m 9
Two Elements for Market Growth

m a zo rro bo tics . co m 10
THE CORE OF THE
SURGICAL
ASSURANCE
PLATFORM
Integrating multiple
data sources,
analytical tools,
guidance and
imaging
technologies to
maximize procedure
predictability
and patient benefit 11
THE MAZOR X VISION - CONNECTIVITY, DATA AND GUIDANCE

Executive Analytics Resource Data mining and analytics to

for: streamline:
Hospita Tool & Implant Implan Inventory management
Quality
OR efficiencies
l MGMT Guidance t Resource forecast
Resource planning Vendo Clinical database
Control and monitoring r

Statistical analysis of
Payer outcomes and surgery
Pre-Op
Analytics OR Hub
Connectivity

Innovation leadership
Holistic approach for predictable
Enhanced abilities
complex and simple surgery
Enables MIS
Patient Data Processing Surgeo Surgical efficiencies and quality
even in long fusions & Display ns Peace of mind
Differentiation

m a zo rro bo tics . co m 12
 Addressing Market Needs

US Health Clinical Trends Surgical Robotics Spine Surgery

Providers
QUALITY Patients demanding Robotics have a place Commoditization of
MIS/ Surgeons in the Operating Room Implants
Thousands of clinical
hesitating
procedures performed Portfolio of products Strategic Alliance &
using the Mazor Global Alignment and Road Map
technology OR Hub
MIS enabling platform
Maintaining an Open
Surgical Assurance platform
platform

m a zo rro bo tics . co m 13
Mazor & Medtronic Co-Promotion 2 Stage Agreement:
From Agreement to Implementation

Marketing Professional Education Sales

Joint workstreams and
global workshops focusing
on messaging, targeting and
positioning
/Bioskills Hundreds of experienced
~150 surgeons participated in Medtronic and Mazor sales reps,
Mazor X training labs to drive sales of Mazor X
5 Mazor X demo systems Extensive US sales rep coverage
installed at Medtronic training geographic depth and breadth
sites

m a zo rro bo tics . co m 14
Mazor Innovation Changing how Spine Surgery is
Performed
Advanced Products
X-Align *- Biomechanical logic
based 3D surgical tools for full
per-patient spine alignment
ArcAid * Robotic production to
implement planning results
Co-Development Future Vision
Pipeline Connectivity & Data analytics
Pre-loading of Medtronic Automation
implants
Leveraging core technology and
Full integration of MDT implant experience in new synergistic
and imaging technology with markets
Mazor X
Wire-free MIS implant placement
*Pending FDA clearance, Not for msale
a zo rro bo tics . co m 15
New Mazor Financial Model More Revenue Sources

Capital Sales (List Prices) Per Case Revenue Service Revenue

Mazor X Disposable Kits: List Price Annual Service revenues:

Price: $1,500
10% of system price
$1,100,000
Medtronic Synergy revenue:
Renaissance: ~$1,000
$650,000 m a zo rro bo tics . co m 16
(*) per procedure when Medtronic implant
Scalable Business Model

m a zo rro bo tics . co m 17
 Growing Commercial Installed
onsistent sequential and annual global growthBase

a lig n w ith exp e r ien ce . co m 18

Historic Financial Results

m a zo rro bo tics . co m 19
Balance Sheet

m a zo rro bo tics . co m 20
MAZOR ROBOTICS ALIGN WITH EXPERIENCE

Surgery Assurance Expanded Co-

Market Platform Developed
Access Product offering

Ready for accelerated

growth
m a zo rro bo tics . co m 21
m a zo rro bo tics . co m 22